Imatinib Unknown Status Phase 1 Trials for Graft Versus Host Disease (GVHD) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00760981A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease